Status:
UNKNOWN
T-EUS for Gastrointestinal Disorders: A Multicenter Registry
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Cholangiocarcinoma
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this registry is to record information and evaluate the impact of Endoscopic Ultrasound (EUS) Guided Endoscopic retrograde cholangiopancreatography (ERCP) on the management of pancreati...
Detailed Description
Endoscopic Ultrasound (EUS) Guided Endoscopic retrograde cholangiopancreatography (ERCP) has become a therapeutic intervention for the management of biliary obstruction or pancreatic strictures relate...
Eligibility Criteria
Inclusion
- Any patient who has undergone EUS-guided ERCP (Endoscopic Retrograde Cholangiopancreatography)for diagnosis or treatment of a pancreatico-biliary disorder.
- Above 18 years of age.
Exclusion
- Any subject who has not undergone Endoscopic Ultrasound (EUS) guided Endoscopic retrograde cholangiopancreatography (ERCP).
- Below 18 years of age.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2018
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01522573
Start Date
November 1 2011
End Date
December 30 2018
Last Update
February 20 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medical College
New York, New York, United States, 10021
2
Prof. Dr. Everson L.A. Artifon
São Paulo, Brazil, 01246-903